You are here

Crohn's Disease

AbbVie’s Skyrizi Outperforms J&J’s Stelara in Late-Stage Crohn’s Disease Trial

AbbVie’s Skyrizi Outperforms J&J’s Stelara in Late-Stage Crohn’s Disease Trial

BioSpace

Crohn's Disease

clinical trials

Flag link:

AbbVie’s Humira to Take Hit from Biosimilars, Next-Gen Therapies: Report

AbbVie’s Humira to Take Hit from Biosimilars, Next-Gen Therapies: Report

BioSpace

Crohn's Disease

Flag link:

Roche in Talks to Buy Stomach Drug from Roivant for $7B: Report

Roche in Talks to Buy Stomach Drug from Roivant for $7B: Report

BioSpace

ulcerative colitis

Crohn's Disease

Flag link:

AbbVie's Rinvoq scores its 7th FDA nod, this one for Crohn's disease

AbbVie's Rinvoq scores its 7th FDA nod, this one for Crohn's disease

Fierce Pharma

Crohn's Disease

Flag link:

Amgen invests in TScan’s TargetScan platform for Crohn’s Disease breakthroughs

Amgen invests in TScan’s TargetScan platform for Crohn’s Disease breakthroughs

Medical Marketing and Media

Crohn's Disease

Flag link:

Galapagos' Jyseleca flops phase 3 Crohn's study, dealing another blow to troubled JAK inhibitor

Galapagos' Jyseleca flops phase 3 Crohn's study, dealing another blow to troubled JAK inhibitor

Fierce Pharma

Crohn's Disease

clinical trials

Flag link:

BMS' Zeposia and AbbVie's Skyrizi Shake Up First-Line Prescribing Patterns in the US Ulcerative Colitis and Crohn's Disease Markets, Spherix Reports

BMS' Zeposia and AbbVie's Skyrizi Shake Up First-Line Prescribing Patterns in the US Ulcerative Colitis and Crohn's Disease Markets, Spherix Reports

PR Newswire

Bristol Myers Squibb

ulcerative colitis

Crohn's Disease

gastroentrologists

Flag link:

Pfizer, Gilead and others seek clarifications on trial designs outlined in FDA's UC and Crohn's draft guidance

Pfizer, Gilead and others seek clarifications on trial designs outlined in FDA's UC and Crohn's draft guidance

Endpoints

Gilead Sciences

ulcerative colitis

Crohn's Disease

drug development

Flag link:

FDA guidance machine churns out 8 new documents in less than a week

FDA guidance machine churns out 8 new documents in less than a week

Endpoints

ulcerative colitis

Crohn's Disease

clinical trials

Flag link:

J&J lands Tremfya one-two punch in IBD with first ulcerative colitis win and long-term Crohn's data

J&J lands Tremfya one-two punch in IBD with first ulcerative colitis win and long-term Crohn's data

Fierce Pharma

Crohn's Disease

Flag link:

Takeda bags Japanese approval for Crohn’s cell therapy Alofisel

Takeda bags Japanese approval for Crohn’s cell therapy Alofisel

Pharmaforum

Crohn's Disease

Flag link:

AbbVie, building out its post-Humira future, posts 5 late-stage trial wins for Skyrizi and Rinvoq

AbbVie, building out its post-Humira future, posts 5 late-stage trial wins for Skyrizi and Rinvoq

Fierce Pharma

clinical trials

Crohn's Disease

atopic dermatitis

Flag link:

Landos Biopharma teams up with LianBio for $218M-plus collab and sales deal for 2 immunology assets in Asia

Landos Biopharma teams up with LianBio for $218M-plus collab and sales deal for 2 immunology assets in Asia

Fierce Biotech

Landos Biopharma

ulcerative colitis

Crohn's Disease

Flag link:

Lilly shows more positive Crohn's data for its IL-23 inhibitor as it continues to chase down rivals

Lilly shows more positive Crohn's data for its IL-23 inhibitor as it continues to chase down rivals

Endpoints

Crohn's Disease

clinical trials

Flag link:

Boehringer Ingelheim adds second AI partner in a month

Boehringer Ingelheim adds second AI partner in a month

Endpoints

Boehringer Ingelheim

artificial intelligence

Crohn's Disease

inflammatory bowel disease

Flag link:

Celltrion showcases positive one-year results for subcutaneous formulation of infliximab in patients with active Crohn’s disease and ulcerative colitis

Celltrion showcases positive one-year results for subcutaneous formulation of infliximab in patients with active Crohn’s disease and ulcerative colitis

Pharmaceutical Business Review

clinical trials

Crohn's Disease

ulcerative colitis

Flag link:

Janssen trials ultrasound-guided approach to treating Crohn’s

Janssen trials ultrasound-guided approach to treating Crohn’s

Pharmaforum

guided ultrasound

Crohn's Disease

Flag link:

Takeda doubles down on Finch's microbiome insights, signing up for a second project in Crohn's disease

Takeda doubles down on Finch's microbiome insights, signing up for a second project in Crohn's disease

Endpoints

Finch Therapeutics

Crohn's Disease

Flag link:

Provention Bio's J&J-licensed Crohn's drug stumbles in mid-stage study

Provention Bio's J&J-licensed Crohn's drug stumbles in mid-stage study

Endpoints

Crohn's Disease

clinical trials

Flag link:

$60M B round to propel Landos through Phase II IBD trials

$60M B round to propel Landos through Phase II IBD trials

BioCentury

Landos Biopharma

clinical trials

ulcerative colitis

Crohn's Disease

Flag link:

Pages